Itamar Medical Announces Appointment of Shane Brown as President – U.S.

CAESAREA, Israel, October 19, 2020 -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused
on the diagnosis of sleep apnea and other respiratory sleep disorders, today announced that Shane Brown has been appointed President – U.S., effective
immediately. In the new role, Mr. Brown will oversee commercial strategy and execution in the U.S. as the Company plans to further accelerate its investment
in penetration of the U.S. market.

“We are delighted to welcome Shane to the Itamar leadership team,” stated Gilad Glick, President and Chief Executive Officer of Itamar Medical. “Itamar’s
recent growth has largely been driven by strength in our U.S. core sleep business, as sleep centers continue to adopt our WatchPAT™ ONE product. We’re
confident that Shane’s rich experience and success in growing commercial organizations in the cardiology medical technology sector will provide us with
further leverage and focus as we seek to expand our reach to the estimated 54 - 60 million adults living in the U.S. suffering from sleep apnea.”

Mr. Brown brings more than 20 years of U.S.-based commercial experience, as he has led several efforts of early adoption of emerging therapies in the
medical device, digital health and medtech markets. Most recently, Mr. Brown served as Vice President, Enterprise Accounts at Abbott Laboratories.
Previously, he held several executive-level sales positions with Abbott which he joined through the acquisition of Topera Medical, an AFib Imaging company,
where he led US sales efforts, as well as a range of management positions at St. Jude Medical prior to its acquisition by Abbott Laboratories. Earlier in his
career, Mr. Brown was with AngioDynamics, a leading provider of minimally invasive medical devices used for vascular access.

“The opportunity to join the Itamar team as they further penetrate the sleep apnea testing market in the U.S. and lead the integration of sleep apnea
management to AFib patients’ care pathway was something I could not pass up. I look forward to leveraging my cardiology and AFib background as Itamar
explores new ways to diagnose and treat the large and undiagnosed U.S. patient population suffering from sleep apnea,” stated Mr. Brown.

Mr. Brown holds a BA in Speech Communication from Miami University